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Caspase-3 and apoptosis in experimental chronic renal scarring. pends to a large extent on the apoptosis of infiltrating
Background. Caspase-3 is a member of the caspase enzyme inflammatory cells in addition to their migration out of
family, having a central role in the execution of apoptosis. the kidneys when the initial insult has subsided [2]. OnHowever, the significance of Caspase-3 in the inappropriate
the other hand, inappropriate regulation of apoptosis mayand excessive apoptosis that contributes to the progression of
lead to an ongoing proliferation of these cells within thenon-immune–mediated renal scarring has not been established.
Methods. Kidneys from sham-operated and subtotal ne- kidneys leading to the initiating and progression of renal
phrectomized (SNx) rats were harvested on days 7, 15, 30, 60, fibrosis [1]. The harmful side of apoptosis in relation to
90 and 120 post-surgery. These were analyzed for apoptosis renal scarring pertains to the deletion by this programmed(in situ end labeling of DNA, light and electron microscopy),
cell death process of intrinsic renal cells [3, 4]. Such aCaspase-3 activity (fluorometric substrate cleavage assay), pro-
mechanism has been put forward to explain experimen-tein and mRNA (Western and Northern blotting), as well as dis-
tribution (immunohistochemistry), inflammation (ED-1 immuno- tal progressive glomerulosclerosis [3, 4] and tubular atro-
histochemistry) and fibrosis (Masson’s Trichrome staining). phy [5] and the ensuing tubulointerstitial fibrosis.
Results. Apoptosis, inflammation and fibrosis gradually in-
This has been postulated in the remnant kidney modelcreased in glomeruli, tubules and interstitium of SNx rats. Cas-
of renal scarring in rats, where ongoing deletion of glo-pase-3 was mainly located in damaged tubules, but also was
found in some glomerular and interstitial cells. Little or no merular cells through apoptosis was instrumental in the
staining was noted in sham-operated kidneys. In SNx kidneys, progression of glomerulosclerosis [3]. In the same model,
Caspase-3 activity was significantly increased from day 30 and we have demonstrated the progressive increase in apo-
peaked on day 120 (2.5-fold). This resulted from increases in
ptosis of tubular and interstitial cells, thus contributingthe 17 and 24 kD active protein subunits. The 32 kD precursor
to tubular atrophy and the associated renal fibrosis [6].was increased at all time points (1861% on day 120, P  0.01).
Caspase-3 changes were transcription-dependent with the 2.7 While it is clear that apoptosis is associated with the
kb caspase-3 mRNA significantly increased at all time points progression of chronic experimental and clinical renal dis-
(287% on day 120). Caspase-3 activity was a better predictor of eases [3–6], questions remain as to the causal link and theapoptosis (Std  coefficient  0.347, P  0.05) than Caspase-3
precise mechanisms and mediators linking programmedproteins or mRNA; however, Caspase-3 at all levels correlated
cell death with renal fibrosis. The identification of keywith apoptosis, inflammation and fibrosis (all P  0.01).
Conclusions. Up-regulation of apoptosis in remnant kidneys mediators involved in apoptosis and renal scarring may
is likely to be Caspase-3-dependent as it is associated with allow for therapeutic interventions based on their manip-
increases in Caspase-3 at the activity, protein and mRNA lev- ulations and aimed at inhibiting renal atrophy, fibrosisels. Therefore, Caspase-3 is a potential therapeutic target for
and scarring.the modification of renal cell apoptosis and subsequently renal
An increasing body of evidence suggests that caspasesfibrosis.
(cysteine proteases) play an essential role in both the
regulation and execution phases of apoptotic cell death
Apoptosis plays a dual role in the evolution of renal and act upstream of DNA fragmentation [7, 8]. To date,
scarring with potential beneficial and harmful influences a family of 14 different caspases has been identified that
[1]. The resolution of renal inflammatory changes de- play a role in both inflammation and apoptosis [8]. They
are all produced as inactive precursors (zymogens) that
are processed into the large and small active subunitsKey words: programmed cell death, inflammation, subtotal nephrec-
tomy, kidney lesions, tubular atrophy, fibrosis, inflammation. [9]. Caspases are highly specific with an absolute require-
ment for cleavage after aspartic acid, while individualReceived for publication March 8, 2001
caspase recognize different tetrapeptide motifs, whichand in revised form June 18, 2001
Accepted for publication June 20, 2001 might explain their individual substrate specificity [8].
Caspases have diverse functions, with members of this 2001 by the International Society of Nephrology
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family playing essential roles in both initial signaling for Caspase-3 activity, protein and mRNA analyses. Se-
events (Caspase-8, Caspase-9) and the downstream pro- rum creatinine concentration (standard autoanalyzer tech-
teolytic cleavages (Caspase-3) [7, 8]. Caspase-3 (CPP32, niques) and 24-hour urinary protein excretion (Biuret
YAMA or apopain) is thought to be key executor of method) were determined in each group at all time points.
apoptosis and is activated via the mitochondrial (Bcl-2/
Estimation of renal scarringBax, Caspase-9), death receptor (Fas/FasL, Caspase-8),
or endoplasmic reticulum (Caspase-12) routes [7, 10]. The extent of renal scarring following SNx was deter-
Protease inhibitors, including macromolecular and pep- mined by two authors who were blinded to the experi-
tide-based inhibitors of caspases, are highly effective in mental code according to a previously published arbi-
preventing apoptotic cell death in both in vitro and in trary scale [14–16]. Using a 200 magnification, sections
vivo models of apoptosis [8, 11]. stained with Masson’s Trichrome were scored as follows.
We have recently observed changes of Caspase-3 in For glomerulosclerosis, a normal glomerulus scored 0;
an immune-mediated glomerulonephritis model of renal mild glomerulosclerosis (GS) affecting up to 25% of the
scarring [12]. This suggested that Caspase-3 is associated glomerular tuft scored 1; moderate GS affecting between
with apoptosis, inflammation and fibrosis, and high- 25% and 50% of the tuft scored 2; and severe GS affect-
lighted it as a potential therapeutic target for preventing ing in excess of 50% of the tuft scored 3. Tubulointersti-
renal scarring. However, there are no data concerning tial scarring was defined and scored as: normal tubules
changes of Caspase-3 during the progression of renal with approximately 1000 tubule cells per 200 magnifi-
scarring in non-immune–mediated chronic renal scar- cation field and no expansion of the interstitium scored
ring. With that in mind, we have measured Caspase-3 0; mild tubular atrophy (TA), with approximately 800
activity, protein and mRNA levels throughout the 120- tubular cells per field and interstitial edema or fibrosis
day course of renal scarring in rats submitted to extensive (IF) affecting up to 25% of the section scored 1; moder-
renal ablation, and correlated the observed changes with ate TA with tubular cell number approximately 600 per
those of apoptosis, inflammation and fibrosis during the field and IF affecting 25% to 50% of the section scored
progression of the disease. 2; and severe TA with tubular cell number approximately
400 per field, IF exceeding 50% of the section scored 3.
To determine the level of tubular atrophy, tubular cellsMETHODS
per200 magnification field were counted. The data wereExperimental animals and protocol
collected from a minimum series of 12 randomly selected
Male Wistar rats (Sheffield University strain) weighing
fields in the cortex, or such number of fields until 30
250 to 300 g were subjected to subtotal (5/6) nephrec-
glomeruli had been counted.tomy (SNx). Rats were housed at constant temperature
(20C) and humidity (45%) on a 12-hour light/dark cycle. In situ end-labeling for the detection of apoptotic cells
They were fed ad libitum on standard laboratory rat
In formal calcium-fixed and paraffin-embedded 4 mchow (Lab Sure Ltd., March, Cambridge, UK) and had
sections, fragmented nuclear DNA was labeled in situfree access to tap water. Subtotal nephrectomy was un-
with digoxigenin-deoxyuridine (dUTP) by terminal deoxy-dertaken in 32 rats as a one-step procedure: left 2/3
nucleotidyl transferase (TdT), using the ApopTag Plusnephrectomy through the ligation and ablation of the
peroxidase kit (Appligene Oncor, Illkirch, France) ac-kidney upper and lower poles as well as a right uni-
cording to the manufacturer’s instructions [6, 17]. Briefly,nephrectomy [13]. Rats were sacrificed in groups (N 
after deparaffinization and hydration, sections were di-4 to 6) at days 7, 15, 30, 60, 90 and 120 after SNx. Sham-
gested by incubation with 15 g/mL proteinase K for 15operated rats (N  29) were used as controls, being
minutes at 37C. Endogenous peroxidase was inactivatedsacrificed at the same time points as those with SNx.
by 2% (vol/vol) H2O2 in phosphate-buffered saline (PBS).Rats were housed in metabolic cages for 24 hours prior to
The sections were then immersed in TdT reaction buffer,sacrifice to facilitate urine collection. All the experiments
and incubated with TdT and digoxigenin-dUTP for 60were carried out according to the rules and regulations
minutes at 37C. The slides were transferred to stoplaid down by the Home Office (Animal Scientific Proce-
buffer at 37C for 30 minutes to terminate the reaction.dure Act 1986, UK).
The sections were incubated with the antidigoxigenin-Removed kidney tissue was fixed in formal calcium
peroxidase complex for 30 minutes at 37C and devel-[4% (wt/vol) paraformaldehyde and 2% (wt/vol) calcium
oped by using the 3-amino-9-ethylcarbazole (AEC) sub-chloride, pH 7.4] and paraffin-embedded for histological
strate kit (Vector Laboratories, Peterborough, UK) andand immunohistochemical examination. For electron mi-
counterstained with hematoxylin. For negative controls,croscopy, small tissue blocks were fixed in 2.5% (vol/
slides were incubated in TdT buffer without TdT. Forvol) glutaraldehyde solution in phosphate buffer (pH
7.4). Snap-frozen tissues were stored in liquid nitrogen biochemically induced positive controls, slides were pre-
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treated with 10 g/mL of DNAse I (Sigma, Poole, UK) clonal mouse anti-human -SMA, diluted 1:250; Dako)
antibodies at 4C overnight. The -SMA antibody wasin DNA buffer.
For each experimental animal, more than 30 glomeru- used to detect myofibroblasts typically expressing a high
immunostaining for this cytoskeletal protein [20]. Sec-lar cross-sections and 20 high power (400) fields of
tubulointerstitium were examined blinded to the experi- tions were labeled with biotinylated secondary anti-
mouse or -rabbit IgG at 37C for 30 minutes, with alka-mental code by two authors. The number of in situ end
labeling (ISEL) positive-staining nuclei per glomerulus line phosphatase streptavidin for another 30 minutes and
developed with Fast Red TR/Naphthol AS-MX solution(Gapo), per 400 tubular cells (Tapo), or per interstitial
field (Iapo) was determined, respectively. ISEL of DNA, (Sigma) to produce a bright pink color. Subsequently,
anti-digoxigenin peroxidase antibody was applied to thewhile associated with apoptosis, also can be seen in ne-
crotic (nonspecific DNA degradation) and mitotic (tran- sections and revealed by the addition of diaminobenzi-
dine to provide positive staining as a yellow/brown color.sient DNA strand break) cells. To substantiate the speci-
ficity of our results, apoptosis was confirmed by light Control sections were incubated with non-immune nor-
mal mouse IgG or normal rabbit serum in place of pri-microscopic evaluation of the characteristic morpholog-
ical features; only strongly positive ISEL cells with ob- mary antibody and with the omission of TdT enzyme as
ISEL controls.servable morphological features of apoptosis such as
shrunken cells with condensed nuclei surrounded by a
Detection of Caspase-3 activity in renal tissuenarrow cytoplasmic halo were counted [4, 6, 18, 19].
The modified Fluorometric CaspACEAssay System
Evaluation of distribution of Caspase-3 and cellular (Promega, Cambridge, UK) was used to detect the activ-
inflammation (ED-1) by immunostaining ity of Caspase-3 in tissue. Kidney tissue (20 to 50 mg) from
control and SNx rats was ground in liquid nitrogen usingLocalization of Caspase-3 and ED-1 (a specific mono-
cyte/macrophage marker) was performed in paraffin- a pestle and mortar. A 1:9 (wt/vol) tissue:buffer extract
was prepared in Tris/acetate buffer, pH 7.5, at 30C [21].embedded kidney tissues by immunohistochemistry using
a standard avidin-biotin peroxidase complex technique as The extract was centrifuged at 12,000  g for 10 minutes
and supernatant was collected. A volume of supernatantdescribed previously [15]. ED-1 immunostaining was ana-
lyzed to evaluate the cellular inflammation. Sections were equivalent to 100 g protein was assayed for Caspase-3
activity by the ability to cleave the florigenic substratepretreated with 0.25% or 0.125% (wt/vol) trypsin at 37C
for 10 minutes. A polyclonal rabbit anti-human Caspase-3 Ac-DEVD-AMC. The specificity of the assay was deter-
mined using the Caspase-3 inhibitor Ac-DEVD-CHO byantibody (Pharmingen, San Diego, CA, USA) recogniz-
ing the 32 and 17 kD Caspase-3 subunits with no cross adding to the sample 30 minutes before the substrate.
Proteolytic cleavage of the substrates was monitored inreactivity against other caspase family members (manu-
facturer’s specification) or a monoclonal mouse anti-rat a fluorescence microplate reader (SOFTmax PRO; Mo-
lecular Devices Corp., Sunnyvale, CA, USA) using anED1 antibody (Serotec Ltd., Oxford, UK) were diluted
1:100 or 1:50 and then applied overnight at 4C in a excitation wavelength of 360 nm and an emission wave-
length of 460 nm. The fluorescence intensity was cali-humid atmosphere. Thereafter, the sections were stained
by an avidin-biotinylated HRP procedure using a com- brated with standard concentrations of AMC, and the
Caspase-3 activity calculated from the slope of the re-mercially available kit (ABC Elite, Vector Labora-
tories). AEC was used as the substrate. Finally, sections corder trace and expressed in picomols per minute per
g of protein at 30C.were counterstained with hematoxylin and mounted in
Glycergel (Dako, Glostrup, Denmark). Negative control
Measurement of tissue Caspase-3 protein levelsections were incubated with normal mouse IgG or nor-
mal rabbit serum at the same protein concentration as Tissue level of Caspase-3 protein was determined by
immunoprobing of Western blots. Ten percent (wt/vol)the primary antibody. The immunohistochemical stain-
ing pattern of ED-1 was semiquantitatively assessed us- tissue homogenate was prepared in the STE buffer [0.32
mol/L sucrose, 5 mmol/L Tris, 2 mmol/L ethylenedi-ing the same counting system as with the ISEL staining.
aminetetraacetic acid (EDTA), 1 mmol/L phenylmethyl-
Double staining for both apoptosis and Caspase-3, sulfonyl fluoride (PMSF), 5 mmol/L benzamidine and 20
ED-1 or -smooth muscle actin g/mL leupeptin], then centrifuged at 4C, 14,000  g
for 10 minutes. Twenty micrograms of protein from theDouble immunohistochemical staining was under-
taken on paraffin sections. ISEL was carried out as de- supernatant was separated on a 15% (wt/vol) poly acryl-
amide denaturing gel and then electro-blotted onto Hy-scribed above. Before application of the anti-digoxigenin
antibody, sections were pre-incubated with blocking se- bond-C nitrocellulose membranes (Amersham Life Sci-
ence, Little Chalfont, UK). Membranes were blockedrum for 30 minutes, labeled with the anti Caspase-3, anti-
ED-1 or anti--smooth muscle actin (-SMA; mono- by the addition of 3% (wt/vol) bovine serum albumin
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(BSA) in 0.1% (vol/vol) Tween 20 TBS (TTBS) at 4C removed using a SephadexG-50 NICK column (Phar-
macia Biotech, UK).overnight before being probed with a polyclonal rabbit
Prehybridization and hybridization were performedanti-rat full-length Caspase-3 (Santa Cruz Biochemicals,
using the Church buffer system (0.5 mol/L sodium phos-Santa Cruz, CA, USA) at 1:2,000 dilution in TTBS buffer
phate and 7% SDS) at 65C [25]. The filter was washedat room temperature for two hours. Primary antibody
three times in church wash buffer (40 mmol/L sodiumbinding was revealed using an anti-rabbit peroxidase
phosphate, 1% SDS) at 65C for 20 minutes and thenconjugate (Dako) diluted at 1:2,000 in TTBS buffer for
exposed to Kodak Biomax MS film for 24 hours. Auto-one hour and the ECL chemiluminescent detection sys-
radiographs were quantitatively analyzed by scanning vol-tem (Amersham Life Science). Recombinant Caspase-3
ume density using a Bio-Rad GS-690 densitometer and(17 kD and 12 kD subunits; Sigma) was used to verify
Molecular Analyst version 4 analysis software (Bio-Radantibody efficacy under experimental conditions. Devel-
Laboratories Ltd.). Optical density values for Caspase-3oped films were semiquantitatively analyzed by volume
were corrected for loading using the housekeeping genedensity using a Bio-Rad GS-690 scanning densitometer
cyclophilin [12, 26]. Results were expressed as percent-and Molecular Analyst version 4 software (Bio-Rad Lab-
age of control sample mRNA densities. Transcript sizeoratories Ltd, Hertfordshire, UK). Translation size was
was determined by comparison to RNA molecular weightdetermined by comparison to protein molecular weight
markers (Promega) using the same analysis package andmarkers (Bio-Rad Laboratories Ltd.) using the same
by visual comparison to the ribosomal RNA subunits.analysis package.
Statistical analysisNorthern blot analysis of Caspase-3 mRNA
Results are expressed as mean 	 standard error ofNorthern blot analysis was carried on the snap-frozen
the mean (SEM). The statistical difference was assessedkidney tissues. Total RNA was extracted using the TRI-
by a single factor variance (ANOVA) or the Student tzol reagent (Life Technologies BRL, Paisley, UK) and
test. Linear correlation analysis using GraphPad InStatquantified by scanning spectrophotometer at 260 nm.
(GraphPad Software Inc., San Diego, CA, USA) andFifteen micrograms of total RNA were electrophoresed
multiple linear regression analysis using SSPS (SPSS Inc.,on a 1% (wt/vol) agarose/3-(N-Morpholino) propane
Chicago, IL, USA) were applied to determine the corre-sulfonic acid (MOPS)/formaldehyde gel. RNA was then
lation and association between parameters. P 0.05 wastransferred to a nylon membrane (Hybond-N, Amer-
considered to be significant.sham Life Science) by capillary blotting using 20  SSC
and cross-linked to the nylon filter using a UV crosslinker
RESULTS(Amersham Life Science) at 70 mJ/cm2 energy [22, 23].
To produce a Caspase-3 cDNA probe, Caspase-3 exo- Renal function and histology studies
nic DNA was amplified from rat cDNA by the polymer- Proteinuria in SNx rats was significantly raised from
ase chain reaction (PCR) using the following previously day 30 (SNx 40.4 	 8.0 mg/24 h vs. Sham 9.3 	 0.7 mg/
published primers: 5-sense ATGGACAACAACGAA 24 h, P  0.05) while serum creatinine was significantly
ACCTCCGTG, 3-antisense CCACTCCCAGTCATTC raised from day 7 (SNx 68.5 	 5.8 mol/L vs. Sham
CTTTAGTG [24]. Amplification reactions were per- 33.8 	 3.1 mol/L). Both reached maximum levels on
formed with 100 mol/L of each dNTP in amplification day 120 (proteinuria, SNx 256.8	 56.8 mg/24 h vs. Sham
buffer (containing 1.5 mmol/L MgCl2) and 1 unit Taq 7.4 	 0.8 mg/24 h; serum creatinine, SNx 140.6 	
polymerase at 85C for five minutes, before 20 picomoles 36.5 mol/L vs. Sham 40.0 	 1.4 mol/L; Table 1). Sig-
of primers were added. Thirty-nine cycles of amplifica- nificant evidence of GS (0.22 	 0.10), TA (936 	 26
tion were completed using the following conditions: tubular cells per 200 field) and IF (0.32 	 0.13 at 200
94.6C for one minute, 48C for one minute, 72C for field) following SNx was noted from day 7 and progres-
two minutes. The 850 bp PCR product was cloned into sively increased thereafter. Maximum changes were re-
the pCR2.1 vector (Invitrogen, UK). Following bacte- corded on day 120 after SNx with GS reaching 1.86 	
rial amplification and plasmid purification, the Caspase-3 0.15, TA at 613.62 	 47.54 tubular cells per 200 field
insert was excised with BstXI and EcoRV, separated by and an IF score of 1.93 	 0.24 at 200 field (Table 1).
electrophoresis on a 1.5% (wt/vol) agarose TAE gel and This indicated the progressive renal insufficiency and a
purified using Prep-A-Gene DNA Purification Systems moderate degree of renal scarring as previously docu-
(Bio-Rad Laboratories Ltd., Hertfordshire, UK). Prod- mented in our earlier studies using this model [6].
uct confirmation was by restriction mapping using EcoRI
Detection of apoptotic cellsand KpnI [12]. Purified cDNA was random primed with
32P-labeled dCTP (NEN, USA) using the Prime-a-Gene Using ISEL, very few apoptotic cells were noted in
the glomeruli, tubules and interstitium of sham-operatedLabeling System (Promega). Unincorporated label was
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Table 1. Changes with time in renal fibrosis, apoptosis and inflammation in the kidneys of rats submitted to subtotal nephrectomy (SNx)
UP SCr
Days mg/24 h lmol/L GS TA IF Gapo Tapo Iapo Ged-1 Ied-1
7 SNc 6.5	0.7 33.8	3.1 ND 1000	0 ND 0.02	0.01 0.09	0.01 0.17	0.02 0.17	0.07 2.02	0.19
SNx 16.9	4.5a 68.5	5.8a 0.22	0.10b 936	26b 0.32	0.13b 0.06	0.02 1.08	0.24b 0.43	0.05c 1.50	0.43a 4.08	0.69a
15 SNc 9.3	2.7 42.6	2.4 ND 1000	0 ND 0.01	0.01 0.09	0.01 0.14	0.04 0.19	0.07 1.86	0.41
SNx 16.7	2.8 84.2	7.9a 0.18	0.06b 943	12b 0.27	0.06b 0.07	0.02a 0.92	0.08b 0.46	0.06b 6.86	0.84c 9.60	1.50c
30 SNc 9.3	0.7 53.8	4.2 ND 1000	0 ND 0.03	0.01 0.06	0.02 0.18	0.02 0.22	0.13 2.05	0.41
SNx 40.4	8.0a 78.7	6.4a 0.34	0.05b 892	13b 0.54	0.06b 0.12	0.03a 1.09	0.22b 0.73	0.10b 4.08	0.20b 10.50	1.91b
60 SNc 7.7	2.1 42.5	1.8 ND 996	4 0.02	0.02 0.02	0.01 0.10	0.01 0.18	0.03 0.15	0.15 1.98	0.37
SNx 131.1	23.0a 107.4	28.5 0.73	0.13b 763	49b 1.18	0.25b 0.10	0.01c 1.66	0.14c 0.85	0.12b 7.50	1.66b 17.40	3.23c
90 SNc 9.9	1.1 53.4	5.6 ND 1000	0 ND 0.02	0.01 0.08	0.01 0.21	0.04 0.46	0.15 3.74	0.75
SNx 234.1	45.4a 111.2	19.9a 1.67	0.16c 653	39c 1.73	0.20c 0.21	0.04b 2.09	0.53b 0.96	0.31a 12.80	2.65c 21.80	3.65c
120 SNc 7.4	0.8 40.0	1.4 ND 1000	0 ND 0.03	0.02 0.06	0.02 0.11	0.03 0.48	0.16 3.98	0.83
SNx 256.8	56.8a 140.6	36.5a 1.86	0.15c 613	48c 1.93	0.24c 0.25	0.04c 2.77	0.44c 1.04	0.25b 15.90	3.64c 27.40	4.78c
Data represent mean 	 SEM. Statistical significance when compared to respective control.
Abbreviations are: SNc, sham-operated (N  4); SNx, subtotally nephrectomized (N  6); UP, proteinuria; SCr, serum creatinine; GS, glomerulosclerosis; TA,
tubular atrophy; IF, interstitial edema or fibrosis; Gapo, apoptotic cells per glomerulus; Tapo, apoptotic cells per 400 tubular cells; Iapo, apoptotic cells per 400
field; Ged1, ED-1 positive-staining cells per glomerulus; Ied1, ED-1 positive-staining cells per 400 field.
a P  0.05, b P  0.01, c P  0.005 and ND, not detectable
rats. Remnant kidneys demonstrated a significant and 400 field; Fig. 1J). In contrast, ED-1 staining cells were
gradually and significantly increased throughout the ex-gradual increase in positively stained nuclei in the glo-
perimental time course in SNx kidneys with a peak onmeruli from day 15 (SNx 0.07 	 0.02 vs. Sham 0.01 	
day 120 in the glomeruli (15.90 	 3.64 per glomerulus)0.01 per glomerulus), in the tubules from day 7 (SNx
and interstitium (27.40 	 4.78 per 400 field; Table 1).1.08 	 0.24 vs. Sham 0.09 	 0.01 per 400 tubular cells)
ED-1
 cells were distributed in inflamed or scleroticand in the interstitium from day 7 (SNx 0.43 	 0.05 vs.
glomeruli (Fig. 1K), expanded interstitium (Fig. 1L) andSham 0.17 	 0.02 per interstitial field at 400) until the
dilated tubular lumens (Fig. 1M).end of the time course. Maximum changes were seen at
day 120 for apoptosis in glomeruli (SNx 0.25 	 0.04 vs.
Double staining for ED-1, -SMA and Caspase-3Sham 0.03 	 0.02), tubules (SNx 2.77 	 0.44 vs. Sham
with apoptosis0.06 	 0.02 cell per 400 tubular cells) and interstitium
Double staining cells of Caspase-3 and ISEL were(SNx 1.04	 0.25 vs. Sham 0.11	 0.03 cell per interstitial
noted in glomerular cells (Fig. 1H) and atrophied tubularfield at 400; Table 1). The highest rates of apoptosis
cells (Fig. 1I). In remnant kidneys ED-1 and ISEL dou-were in the sclerotic glomeruli (Fig. 1A), dilated or atro-
ble-staining, positive cells were found in inflamed inter-phied tubules (Fig. 1B) and expanded interstitium (Fig.
stitium (Fig. 1N) and glomeruli (not shown). Some cells1C). In positive control sections treated with DNAse I
stained positively for both apoptosis (ISEL) and -SMAbefore the TdT reaction, nearly all of the cells stained,
in the interstitium (Fig. 1O).but most of positive nuclei showed normal shape, and
no cytoplasmic condensation. No staining was present
Caspase-3 activityin the negative control sections using buffer lacking TdT
(data not shown). Electron microscopy confirmed apo- There was a gradual increase in Caspase-3 protease
ptotic cells with distinct morphological motifs (Fig. 2). activity in SNx rat kidneys at all time points compared
with the controls reaching significance by day 30 and
Distribution of Caspase-3 and detection of cellular reaching a peak on day 120 (2.5-fold of control; Fig. 3).
inflammatory ED-1 The specific and competitive tetrapeptide inhibitor of
Caspase-3, Ac-DEVD-CHO, almost fully inhibited theThere was no or very faint Caspase-3 immunostaining
Caspase-3 activity in the assays, demonstrating assayin sham-operated kidneys (Fig. 1D). In contrast, Cas-
specificity (data not shown).pase-3 staining was seen in dilated tubules (Fig. 1E),
damaged glomerular capsule and a few glomerular cells
Tissue level of Caspase-3 protein(Fig. 1E), the loop of Henle (Fig. 1F) and interstitial
cells (Fig. 1G) of remnant kidneys. Some Caspase-3 posi- Western blot analysis showed a considerable variation
tive cells had the typical morphological features of apo- in Caspase-3 levels in animals from the same experimen-
ptosis (Fig. 1G). tal groups in this study (Fig. 4). However, the magnitude
In kidneys from sham-operated rats, a small number of the observed changes was statistically significant. The
of ED-1 positive cells were seen in the glomeruli (0.28	 17 kD Caspase-3 active subunit was significantly in-
creased from day 30 onwards in SNx kidneys with maxi-0.12 per glomerulus) and interstitium (2.61 	 0.49 per
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mal expression on day 120 (1942% of control). A 24 kD 0.573; and 32 kD, r  0.577; and mRNA, r  0.642, all
P  0.01), inflammation (activity, r  0.722; 17 kD, r band also representing a Caspase-3 active subunit was
gradually and significantly increased at all time points, 0.642; 24 kD, r 0.621; and 32 kD, r 0.544; and mRNA,
r  0.805, all P  0.01) and fibrosis (activity, r  0.728;reaching a peak on day 120 (921% of control). The 29
kD Caspase-3 processing intermediate was present in all 17 kD, r  0.679; 24 kD, r  0.711; and 32 kD, r  0.589;
kidneys throughout the time course. The 32 kD precursor and mRNA, r  0.818, all P  0.01). Among Caspase-3
of Caspase-3 was significantly increased as early as day activity, protein and mRNA, multiple regression analysis
7 (747%), peaked on day 60 (2704%), and then dropped showed that Caspase-3 activity was the best predictor
with time until day 120 (1861% of control). This was in of apoptosis (Std  coefficient  0.347, P  0.05) and
contrast with the continuous increase of both 17 kD and Caspase-3 mRNA was a better predictor of inflammation
24 kD active subunits (Fig. 4). and fibrosis (Std  coefficient  0.435 and 0.394 respec-
To validate antibody reactivity, Western blots were per- tively, P  0.01).
formed utilizing recombinant active Caspase-3 protein.
The full length Caspase-3 antibody strongly bound with
DISCUSSION12 and 17 kD recombinant Caspase-3 proteins (Fig. 4).
Subtotal nephrectomy in rats is a non-immune medi-
Expression of Caspase-3 mRNA ated experimental model of chronic renal scarring [27].
Previously we described a progressive and sustained in-Northern blot analysis revealed the expression of a
crease in the number of apoptotic cells in the glomeruli,Caspase-3 mRNA transcript at 2.7 kb (Fig. 5). In compar-
tubules and interstitium in this model, with maximalison with the control rat kidneys, the level of Caspase-3
apoptosis detected in sclerotic glomeruli, atrophied tu-mRNA was significantly increased at all time points, and
bules and expanded interstitium [6]. Further studies inreaching a peak at day 120 (287% of control; Fig. 5).
this model have demonstrated that apoptosis is likely to
Correlation between apoptosis, inflammation, fibrosis be influenced by the interplay between Bax (pro-apo-
and Caspase-3 ptotic antigen) and Bcl-2 (anti-apoptotic antigen) with
changes at both the mRNA and protein levels [28]. AnCellular apoptosis in glomeruli, tubules and intersti-
increase in Bax coupled with a decreased level of Bcl-2tium closely correlated with inflammation (r  0.403,
was shown to have strong associations with the changes0.820 and 0.732, P  0.01), as well as with GS, TA and
in apoptosis and the progression of renal scarring [28].IF (r  0.871, 0.873 and 0.773, P  0.01 [28]). Cellular
In this study, we extended our observations to encompassinflammation also positively correlated with GS, TA and
Caspase-3, which is thought to be a key enzyme for theIF (r  0.679, 0.698 and 0.698, P  0.01). Multiple
execution of the apoptotic program [7, 8]. There is a clearregression analysis showed that apoptosis was more
up-regulation of Caspase-3 activity that is dependent onclosely associated with GS and TA (Std  coefficients 
changes not only at the translation and transcription levels,0.531 and0.723, respectively, P 0.01) than inflamma-
but also by post-translational modification of the latenttion or proliferation and interstitial inflammation was
more closely related with IF (Std  coefficients  0.458, precursor. Multiple regression analysis demonstrated
that Caspsase-3 activity was the best predictor of apopto-P  0.01) than apoptosis and proliferation (refer previ-
ous data [6]). sis and strongly correlated with its protein and mRNA
levels. Furthermore, we have highlighted changes inThere were close associations between the expression
of Caspase-3 activity and proteins (17 kD, r  0.512 and Caspase-3 that are consistent with variations in apopto-
sis, inflammation and fibrosis over the time course.24 kD, r  0.440, P  0.01; and 32 kD, r  0.302, P 
0.05); proteins and mRNA (17 kD, r  0.634; 24 kD, The caspase enzyme family, and in particular Caspase-3,
has a central role in the execution of apoptosis that re-r 0.637; and 32 kD, r 0.583, all P 0.01); and activity
and mRNA (r  0.698, P  0.01). The Caspase-3 at sults in the phenotype of apoptosis. Caspase-3 is trans-
lated as an inactive 32 kD precursor that is proteolyticallydifferent levels positively correlated with overall apopto-
sis (activity, r  0.589, 17 kD, r  0.530; 24 kD, r  processed to become a functionally active enzyme [29–32].

Fig. 1. (A–C) Positive apoptotic cells (indicated by arrows) in glomeruli (A, 400), tubules (B, 200) and interstitium (C, 400) of subtotally
nephrectomized (SNx) kidneys by ApopTag staining. (D–I) Caspase-3 immunostaining in sham-operated (D, 200) and remnant kidneys (E–G)
within the dilated tubules (E, 200; G, 400), glomerulus (E), loops of Henle (F, 200) and interstitial cells (G). (H and I) Double staining of
Caspase-3 (bright pink) with ISEL (brown) in the glomerulus (H, 800) and atrophied tubule (I, 800) in the remnant kidney with dark brown
indicating composite staining. (J–M) ED-1 positive cells in the glomerulus and interstitium of sham-operated rat kidney (J, 200), and in glomeruli,
interstitium (K and L, 100) and tubular lumen of remnant kidneys (M, 200). (N and O) Double staining of ISEL (brown) with ED-1 (bright
pink) (N, 400) and -smooth muscle actin (-SMA; bright pink; O, 1000) in the interstitium of SNx kidneys.
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Activation of Caspase-3 requires two proteolytic cleav-
age events. Removal of the NH2 terminal pro-domain
generating a 29 kD processing intermediate that is subse-
quently cleaved into 17 kD and 11 kD or 12 kD subfrag-
ments [30–32]. However, other active fragments, such as
24, 20 and 18 kD, have also been reported [12, 24, 33].
These subfragments then heterodimerize to form the
activated protease [31, 32].
In this SNx model, Western blot analysis of remnant
kidneys showed significant increases in both the 17 kD
and 24 kD subunits representing active Caspase-3. The ap-
pearance of the active Caspase-3 fragments correlated
well with the changes in enzyme activity. However, while
elevated, Caspase-3 mRNA did not increase in line with
the Caspase-3 activity. Thus, the changes in activity due
to the increases in 17 kD and 24 kD proteins would ap-
pear to be a consequence of changes in level of activation
of the 32 kD Caspase-3 precursor, rather than solely down
to an increased transcriptional rate. This also explains the
decrease in 32 kD protein at the latter time points in
spite of a continuing up-regulation of the mRNA levels,
suggesting this de novo Caspase-3 precursor is immedi-
ately processed to the smaller active forms when apoptosis
is at its highest. Furthermore, the levels of 32 kD Caspase-
3 protein are not wholly consistent with the changes of
Caspase-3 mRNA level at earlier time points. The steadily
increasing levels of the 32 kD protein up to day 60 in
comparison to the static elevation in mRNA level indi-
cates that changes in mRNA stability or alteration to the
rate of translation also may be important in Caspase-3
production.
Immunolocalization of Caspase-3 in rat kidneys has
previously proved difficult with a few studies restricted to
analysis of human tissues [34, 35]. Here for the first time,
we have been able to localize Caspase-3 in paraffin-
embedded rat kidney by pretreating sections with a high
concentration of trypsin and applying an anti-human full-
length Caspase-3 antibody. This revealed no or very faint
Caspase-3 positive immunostaining in sham-operated kid-
neys. Given the substantial levels of Caspase-3 protein
and mRNA detectable in normal kidneys (assumption
made on band development time in Western and Northern
blotting analysis) this would be consistent with a low ex-
pression of Caspase-3 in many cells falling below the
threshold for immunohistochemical detection. In contrast
within remnant kidneys, there was a strong Caspase-3
staining especially in damaged tubules, but also within
some glomerular and interstitial cells. This staining pat-
tern is consistent with that of ISEL, which in combination
Fig. 2. Positive apoptotic cells (indicated by arrows) in glomeruli (A, with double staining provides direct evidence for the
8829), tubules (B,11142) and interstitium (C,6858) of SNx kidneys
involvement of Caspase-3 in apoptosis in this model ofby electron microscopy.
renal scarring. While the location allows identification of
tubular cells as producers of Caspase-3, it is not directly
evident from our study that cell types in the glomeruli
and interstitium have elevated Caspase-3. These may be
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Fig. 3. Activity of Caspase-3 in kidney tissues
assayed by the fluorometric measurement of
AMC cleaved from a specific Caspase-3 sub-
strate. Symbols are: () control; ( ) SNx.
Data represent mean 	 SEM. N  4 for con-
trol and N  6 for SNx. **P  0.01; ***P 
0.001 compared with the control kidneys.
Fig. 4. Western blot analysis for Caspase-3
protein in SNx kidneys on day 7, 15, 30, 60,
90 and 120. A 17 kD band and a 24 kD band,
representing the Caspase-3 active subunit; a
29 kD, representing processing intermediate
of Caspase-3; a 32 kD band, representing the
precursor of Caspase-3. Re-c3: 5 ng recombi-
nant Caspase-3. Symbols are: ( ) control; ( )
17 kD; () control; () 24 kD; ( ) Control;
( ) 32 kD. Data represent the mean percent-
age change in volume density compared to the
average control value (mean 	 SEM). N  4
for control, N 5 for SNx. *P0.05; **P0.01
compared with the control kidneys.
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Fig. 5. Tissue level of Caspase-3 mRNA by
Northern blot analysis in SNx rat kidneys.
Autoradiographs at the top show 2.7 kb Cas-
pase-3 mRNA transcript and the bottom,
cyclophilin 1.8 kb transcript. The histogram
shows the volume density analysis of autora-
diographs corrected for loading using cycloph-
ilin. Data represent the mean percentage
change in volume density compared to the
average control value (mean 	 SEM). N  4
for control and N  6 for SNx. *P  0.05;
**P 0.01 compared with the control kidneys.
either resident renal cells or inflammatory cells. Double other renal injury models associated with apoptosis. For
instance, it was found to be up-regulated at both mRNAstaining for cell markers appears to be a solution, al-
though markers such as ED-1 and -SMA are rapidly and total protein levels during reperfusion in a rat model
of acute renal ischaemia [24]. In addition, increased Cas-lost once the apoptotic pathway has commenced. Given
that most Caspase-3 positive cells are likely to be at some pase-3 activity was reported following the administration
of nephrotoxic doses of cyclosporine A in salt-depletedstage in the apoptotic program and requirement of strong
trypsinization for Caspase-3 immunostaining, then the rats [36].
The staining profile of Caspase-3 reported here is simi-co-localization of a specific cell marker with Caspase-3
has obvious problems. However, we have had some suc- lar to that reported for Bax in remnant kidneys, espe-
cially in dilated tubules, sclerotic glomeruli and fibroticcess double-staining ISEL-positive cells with ED-1 or -
SMA, which by inference suggests that most cells ex- interstitial areas [28]. This indicates that Bax and Cas-
pase-3 may have a coordinating role in the processingpressing Caspase-3 would be monocytes or myofi-
broblasts in the glomeruli and interstitium. of apoptotic cell death. Caspase-3 is potentially the most
important effector enzyme in apoptosis, providing aOther immunohistochemical studies using the same
Caspase-3 antibody in normal human kidneys showed common pathway for death receptor (Fas/FasL), mito-
chondria-dependent (Bax/Bcl-2 related) or endoplasmicstrong positive staining in renal tubule epithelium with
little or no Caspase-3 immunoreactivity in the glomeruli reticulum-mediated apoptosis [7, 10, 37]. In light of our
previous findings of changes in the Bax/Bcl-2 ratio in[35]. The higher tubular staining in normal human kid-
neys may well represent differences between species; how- this model [28], it seems likely that Caspase-3 activation
may be linked with the changes of Bax/Bcl-2.ever, it equally could be due to greater sensitivity of the
antibody for human than rat Caspase-3. Studies describ- While our results clearly implicate Caspase-3 in apo-
ptosis associated with progressive renal scarring, it ising changes in Caspase-3 staining in human scarred tissue
remain to be performed. However, when this is done it important to note that Caspase-3 also is involved in the
inflammation as indicated by the positive correlation be-will be interesting to note if the considerable Caspase-3
staining within the glomeruli and interstitium seen in tween the Caspase-3 activity, proteins, mRNA and cellu-
lar inflammation in remnant kidneys. While the remnantthis experimental model also are evident, as they un-
doubtedly contribute significantly to the Caspase-3 pool. kidney model of renal scarring is not initiated by an
immune response, the progression of fibrosis has beenThe predominantly Caspase-3 tubular epithelial stain-
ing pattern combined with the positive double staining associated with the severity of the late interstitial in-
flammatory infiltrate [27, 38]. This was supported in ourof Caspase-3 and ISEL clearly implicates Caspase-3 in
tubular cell apoptosis and tubular atrophy. Caspase-3 also study by the strong association between the severity of
the monocytic interstitial infiltrate and interstitial fibro-has been reported to be involved in the pathogenesis of
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of apoptosis in glomeruli, tubules and interstitium. Such
Reprint requests to Bin Yang, M.D., Sheffield Kidney Institute, North-a persistent inflammation may favor a microenvironment
ern General Hospital, The University of Sheffield, Herries Road, Shef-
for uncontrolled apoptosis of renal cells. This not only field S5 7AU, England, United Kingdom.
E-mail: Bin.Yang@Sheffield.ac.ukmay be due to the direct action of various inflammatory
cells to instigate apoptosis through cell to cell contact
[39], but also due to the inevitable changes in cytokines REFERENCES
and growth factors that accompany inflammatory cells. 1. Savill J, Smith J, Sarraf C, et al: Glomerular mesangial cells and
inflammatory macrophages ingest neutrophils undergoing apopto-Many of these, such as transforming growth factor-1
sis. Kidney Int 42:924–936, 1992[40–41] and tumor necrosis factor- (TNF-) [42], are
2. Baker AJ, Mooney A, Hughes J, et al: Mesangial cell apoptosis:
highly influential on apoptotic rates. The major mechanism for resolution of glomerular hypercellularity
in experimental mesangial proliferative nephritis. J Clin Invest 94:The pivotal role of Caspase-3 in the apoptosis machin-
2105–2116, 1994ery makes it an attractive target to regulate apoptosis-
3. Sugiyama H, Kashihara N, Makino H, et al: Apoptosis in glomeru-
related cell death. In vitro, the induction of apoptosis in lar sclerosis. Kidney Int 49:103–111, 1996
4. Shimizu A, Masuda Y, Kitamura H, et al: Apoptosis in progressivemouse proximal tubule cells by cisplatin has been inhibited
crescentic glomerulonephritis. Lab Invest 74:941–951, 1996by Ac-Asp-Glu-Val-Asp-H, a known Caspase-3 inhibi-
5. Truong LD, Petrusevska G, Yang G, et al: Cell apoptosis and
tor [43]. Application of this therapeutic approach in vivo proliferation in experimental chronic obstructive uropathy. Kidney
Int 50:200–207, 1996is clearly more problematic, although has met with some
6. Thomas GL, Yang B, Wagner BE, et al: Cellular apoptosis andsuccess despite fears relating to the potential tumorigenic
proliferation in experimental renal fibrosis. Nephrol Dial Trans-
consequences of inhibiting apoptosis. For example, ele- plant 13:2216–2226, 1998
7. Rudel T: Caspase inhibitors in prevention of apoptosis. Herz 24:vated apoptosis of hepatic parenchymal cells during en-
236–241, 1999dotoxemia (TNF-mediated) was prevented by injection
8. Thornberry NA, Rano TA, Peterson EP, et al: A combinatorial
of Z-VAD, a strong Caspase-3 inhibitor [44]. It has been approach defines specificities of members of the caspase family
and granzyme B. Functional relationships established for key medi-also been reported that the administration of B-D-FMK
ators of apoptosis. J Biol Chem 272:17907–17911, 1997(a pan caspase inhibitor) was neuro-protective when
9. Rotonda J, Nicholson DW, Fazil KM, et al: The three-dimen-
given by intra-cerebral or systemic injection after cere- sional structure of apopain/CPP32, a key mediator of apoptosis.
Nat Struct Biol 3:619–625, 1996bral hypoxia-ischemia [45]. More recently, it has been
10. Nakagawa T, Zhu H, Morishima N, et al: Caspase-12 mediatesreported Z-VAD-FMK reduced the Caspase-3 activity
endoplasmic-reticulum-specific apoptosis and cytotoxicity by amy-
and prevented the early onset of not only renal apoptosis, loid-. Nature 403:98–103, 2000
11. Thornberry NA: The caspase family of cysteine proteases. Br Medbut also inflammation and tissue injury in a mouse model
Bull 53:478–490, 1997of renal ischemia [46]. Given these findings a similar
12. Yang B, Johnson TS, Thomas GL, et al: Apoptosis and Caspase-
blockade of Caspase-3 in progressive renal scarring may 3 in experimental anti-glomerular basement membrane nephritis.
J Am Soc Nephrol 12:485–495, 2001provide a novel therapeutic approach to the treatment
13. Muchaneta Kubara EC, El Nahas AM: Myofibroblast pheno-of renal scarring by controlling inappropriate apoptosis
types expression in experimental renal scarring. Nephrol Dial Trans-
of renal cells. plant 12:904–915, 1997
14. Johnson TS, Griffin M, Thomas GL, et al: The role of transglutam-In conclusion, we have demonstrated, to our knowl-
inase in the rat subtotal nephrectomy model of renal fibrosis. J Clinedge for the first time, significant increases in Caspase-3 Invest 99:2950–2960, 1997
at the activity, protein and mRNA levels, which coincide 15. El Nahas AM: Growth factors and glomerular sclerosis. Kidney
Int 41(Suppl 36):S15–S20, 1992with elevated apoptosis in a non-immune mediated
16. Muchaneta Kubara EC, Sayed Ahmed N, El Nahas AM: Subto-chronic renal fibrosis model. During the SNx time course, tal nephrectomy: a mosaic of growth factors. Nephrol Dial Trans-
the increase of Caspase-3 activity was associated with plant 10:320–327, 1995
17. Gavrieli Y, Sherman Y, Ben Sasson SA: Identification of pro-the elevated precursor and active Caspase-3 proteins,
grammed cell death in situ via specific labeling of nuclear DNAwhich resulted from the increase of Caspase-3 mRNA fragmentation. J Cell Biol 119:493–501, 1992
transcription indicating the requirement for de novo syn- 18. Saraste A: Morphologic criteria and detection of apoptosis. Herz
24:189–195, 1999thesis of Caspase-3. Caspase-3 activity was a good pre-
19. Gobe´ G, Zhang XJ, Willgoss DA, et al: Relationship betweendictor of apoptosis occurrence associated with GS and expression of Bcl-2 genes and growth factors in ischemic acute
TA. The manipulation of Caspase-3 could therefore be renal failure in the rat. J Am Soc Nephrol 11:454–467, 2000
20. Zhang G, Moorhead PJ, El Nahas AM: Myofibroblasts and thea therapeutic target for prevention renal cell deletion by
progression of experimental glomerulonephritis. Exp Nephrol 3:uncontrolled apoptosis and the subsequent renal fibrosis. 308–318, 1995
21. Haycock JW, Falkous G, Maltin CA, et al: Effect of prednisone
on protease activities and structural protein levels in rat musclesACKNOWLEDGMENTS
in vivo. Clin Chim Acta 249:47–58, 1996
The authors would like to thank the National Kidney Research 22. Shehata M, Cope GH, Johnson TS, et al: Cyclosporine enhances
Fund, the Northern General Hospital NHS Trust Research Committee, the expression of TGF-beta in the juxtaglomerular cells of the rat
kidney. Kidney Int 48:1487–1496, 1995the Sheffield Kidney Research Foundation and the Sheffield Kidney
Yang et al: Caspase-3 and apoptosis1776
23. Johnson TS, Skill NJ, El Nahas AM, et al: Transglutaminase cal analysis of in vivo patterns of expression of CPP32 (Caspase-3),
a cell death protease. Cancer Res 57:1605–1613, 1997transcription and antigen translocation in experimental renal scar-
ring. J Am Soc Nephrol 10:2146–2157, 1999 36. Shihab FS, Andoh TF, Tanner AM, et al: Expression of apoptosis
regulatory genes in chronic cyclosporine nephrotoxicity favors apo-24. Kaushal GP, Singh AB, Shah SV: Identification of gene family
of caspases in rat kidney and altered expression in ischemia-reper- ptosis. Kidney Int 56:2147–2159, 1999
37. Cohen GM: Caspases: The executioners of apoptosis. Biochemfusion injury. Am J Physiol 274:F587–F595, 1998
25. Shifman MI, Stein DG: A reliable and sensitive method for non- J 326:1–16, 1997
38. Fujihara CK, De Lourdes Noronha I, Malheiros DM, et al:radioactive Northern blot analysis of nerve growth factor mRNA
from brain tissues. J Neurosci Methods 59:205–208, 1995 Combined mycophenolate mofetil and losartan therapy arrests
established injury in the remnant kidney. J Am Soc Nephrol 11:283–26. Douthwaite JA, Johnson TS, Haylor JL, et al: Effects of trans-
forming growth factor-1 on renal extracellular matrix components 290, 2000
39. Mix JE, Zettl UK, Zielasek J, et al: Apoptosis induction byand their regulating proteins. J Am Soc Nephrol 10:2109–2119, 1999
27. El Nahas AM, Paraskevakou H, Zoob S, et al: Effect of dietary macrophage-derived reactive oxygen species in myelin-specific T
cells requires cell-cell contact. Neuroimmunol 95:152–156, 1999protein restriction on the development of renal failure after subto-
tal nephrectomy in rats. Clin Sci 65:399–406, 1983 40. Eddy AA: Experimental insights into the tubulointerstitial disease
accompanying primary glomerular lesions. J Am Soc Nephrol 5:28. Yang B, Johnson TS, Thomas GL, et al: The expression of apopto-
sis-related genes and proteins in experimental chronic renal scar- 1273–1287, 1994
41. Bursch W, Oberhammer F, Jirtle RL, et al: Transforming growthring. J Am Soc Nephrol 12:275–288, 2001
29. Thornberry NA: Interleukin-1 beta converting enzyme. Methods factor-beta 1 as a signal for induction of cell death by apoptosis.
Br J Cancer 67:531–536, 1993Enzymol 244:615–631, 1994
30. Schlegel J, Peters I, Orrenius S, et al: CPP32/apopain is a key 42. Ortiz A, Lorz C, Gonza´lez Cuadrado S, et al: Cytokines and
Fas regulate apoptosis in murine renal interstitial fibroblasts. J Aminterleukin 1 beta converting enzyme-like protease involved in
Fas-mediated apoptosis. J Biol Chem 271:1841–1844, 1996 Soc Nephrol 8:1845–1854, 1997
43. Fukuoka K, Takeda M, Kobayashi M, et al: Distinct interleukin-31. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel
human apoptotic protein with homology to Caenorhabditis elegans 1beta-converting enzyme family proteases mediate cisplatin- and
staurosporine-induced apoptosis of mouse proximal tubule cells.cell death protein Ced-3 and mammalian interleukin-1 beta-con-
verting enzyme. J Biol Chem 269:30761–30764, 1994 Life Sci 62:1125–1138, 1998
44. Jaeschke H, Fisher MA, Lawson JA, et al: Activation of Caspase-332. Sabbatini P, Han J, Chiou SK, et al: Interleukin 1 beta converting
enzyme-like proteases are essential for p53-mediated transcription- (CPP32)-like proteases is essential for TNF-alpha-induced hepatic
parenchymal cell apoptosis and neutrophil-mediated necrosis in aally dependent apoptosis. Cell Growth Differ 8:643–653, 1997
33. Armstrong RC, Aja TJ, Hoang KD, et al: Activation of the CED3/ murine endotoxin shock model. J Immunol 160:3480–3486, 1998
45. Cheng Y, Deshmukh M: DCosta A, et al: Caspase inhibitor affordsICE-related protease CPP32 in cerebellar granule neurons under-
going apoptosis but not necrosis. J Neurosci 15:553–562, 1997 neuroprotection with delayed administration in a rat model of
neonatal hypoxic-ischemic brain injury. J Clin Invest 101:1992–34. Krajewski S, Gascoyne RD, Zapata JM, et al: Immunolocalization
of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non- 1999, 1998
46. Daemen MA, van’t Veer C, Denecker G, et al: Inhibition ofHodgkin’s lymphomas, chronic lymphocytic leukemias, and reac-
tive lymph nodes. Blood 89:3817–3825, 1997 apoptosis induced by ischemia-reperfusion prevents inflammation.
J Clin Invest 104:541–549, 199935. Krajewska M, Wang HG, Krajewski S, et al: Immunohistochemi-
